WallStSmart
UNCY

Unicycive Therapeutics Inc

NASDAQ: UNCY · HEALTHCARE · BIOTECHNOLOGY

$7.66
+6.98% today

Updated 2026-04-30

Market cap
$180.96M
P/E ratio
P/S ratio
23.75x
EPS (TTM)
$-1.67
Dividend yield
52W range
$4 – $11
Volume
0.5M

Unicycive Therapeutics Inc (UNCY) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-160.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-32.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+10.5%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+16.5%
2026-03-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-31$-0.66$6.11$7.12+16.5%
2025-12-31$-0.82-80.0%$5.59$5.80+3.8%
2025-11-12$-0.33-398.5%$4.79$5.33+11.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.66
2025-12-31$-0.46$-0.82-80.0%
2025-09-30$-0.07$-0.33-398.5%
2025-06-30$-0.07$-0.52-642.9%
2025-03-31$-0.10$-0.50-400.0%
2024-12-31$-0.09$0.25+373.5%$568000.00-309.6%
2024-09-30$-0.15$-0.05+66.7%
2024-06-30$-0.20$-0.29-45.0%
2024-03-31$-0.15$-0.61-306.7%
2023-12-31$-0.17$-0.22-29.4%$-271000.00
2023-09-30$-0.12$-0.13-8.3%

Frequently asked questions

Has Unicycive Therapeutics Inc beaten earnings estimates?
Unicycive Therapeutics Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -160.0% over the last 3 quarters.
How does UNCY stock react to earnings?
UNCY stock has moved an average of +10.5% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.